share_log

Redhill Biopharma | EFFECT: Others

Redhill Biopharma | EFFECT: Others

Redhill Biopharma | EFFECT:其他
美股sec公告 ·  04/23 06:04
Moomoo AI 已提取核心信息
RedHill Biopharma Ltd., a biopharmaceutical company, has received a Notice of Effectiveness from the United States Securities and Exchange Commission (SEC) on April 22, 2024. The notice indicates that the company's submission, identified by Accession Number 0001558370-24-005273 and Submission Type POS AM, has been officially accepted by the SEC. The effectiveness of the submission is a significant regulatory milestone for RedHill Biopharma, which is listed under CIK number 0001553846 and file number 333-276979.
RedHill Biopharma Ltd., a biopharmaceutical company, has received a Notice of Effectiveness from the United States Securities and Exchange Commission (SEC) on April 22, 2024. The notice indicates that the company's submission, identified by Accession Number 0001558370-24-005273 and Submission Type POS AM, has been officially accepted by the SEC. The effectiveness of the submission is a significant regulatory milestone for RedHill Biopharma, which is listed under CIK number 0001553846 and file number 333-276979.
生物制药公司RedHill Biopharma Ltd. 已于2024年4月22日收到美国证券交易委员会(SEC)的生效通知。该通知指出,该公司提交的材料已被美国证券交易委员会正式接受,其注册号为0001558370-24-005273,提交类型为POS AM。该提交的有效性是RedHill Biopharma的重要监管里程碑,该公司在CIK下上市,编号为0001553846,文件编号为333-276979。
生物制药公司RedHill Biopharma Ltd. 已于2024年4月22日收到美国证券交易委员会(SEC)的生效通知。该通知指出,该公司提交的材料已被美国证券交易委员会正式接受,其注册号为0001558370-24-005273,提交类型为POS AM。该提交的有效性是RedHill Biopharma的重要监管里程碑,该公司在CIK下上市,编号为0001553846,文件编号为333-276979。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息